DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Genocea Biosciences, Inc. (GNCA)
« Back to company indexGNCA Chatter Timeline
Stock Ticker for GNCA
Most Active Tweeters for GNCA
| User | Tweets |
|---|---|
| @YVR_Trader | 5 |
| @bulletin_en | 5 |
| @Tickeron | 5 |
| @Lin_ling_88 | 4 |
| @BeefEnt | 4 |
Recent Tweets for GNCA
 |
@Ultra_Calls $GNCA Due for a nice run. Watching this one closely tomorrow. ? May 23rd 2019, 5:05pm |
 |
@registrarjourn Genocea Biosciences $GNCA Upgraded to Buy at ValuEngine https://t.co/onInhuXDh5 May 23rd 2019, 2:05am |
 |
@EnterpriseLeade Genocea Biosciences $GNCA Upgraded to Buy at ValuEngine https://t.co/BuweTd8a30 May 23rd 2019, 2:05am |
 |
@Tickeron $GNCA Genocea Biosciences (GNCA, $4.75) was the month's biggest loser, shedding -15% https://t.co/SRAkrSANWl May 23rd 2019, 12:05am |
 |
@SzhaoTrader $GNCA Genocea Biosciences 8-K Shows News Of 1-For-8 Reverse Stock Split Effective May 22, 2019. Don’t get confused. May 22nd 2019, 9:05pm |
 |
@Lin_ling_88 Dr.Gottlieb has returned to VC #NEA who owns both $GNCA and $MRKR heavily. No way this is negative. https://t.co/elzZYNMxm9 May 22nd 2019, 6:05pm |
 |
@rajramaswamy RT @Lin_ling_88: $GNCA $MRKR Ex-FDA Commissioner Dr. Gottlieb has returned to his old gig at NEA; it’s comforting to know NEA remainsTHE to… May 22nd 2019, 6:05pm |
|
@Lin_ling_88 $GNCA $MRKR Ex-FDA Commissioner Dr. Gottlieb has returned to his old gig at NEA; it’s comforting to know NEA remain… https://t.co/jm57XmSozX May 22nd 2019, 6:05pm |
|
@Tickeron $GNCA Genocea Biosciences (GNCA, $4.75) was the stock market's top loser yesterday, falling -10.47% https://t.co/6WTkys5NIO May 22nd 2019, 5:05pm |
|
@Tickeron A.I.dvisor made a bearish call on $GNCA, netting in a 17.91% gain over 6 days https://t.co/YD1sz2otGK https://t.co/mYWINNmOMN May 22nd 2019, 5:05pm |
 |
@bulletin_en Reviewing Global Cord Blood Corporation $GNCA's results https://t.co/uDOdlHyI5H May 22nd 2019, 2:05pm |
 |
@sarkoconsulting $gnca reverse split check back in a month probably can get it lower #biotech #stocks May 22nd 2019, 12:05pm |
|
@Tickeron $GNCA Genocea Biosciences (GNCA, $4.75) was this week's top stock market loser, declining -17% https://t.co/FIvRSzIuJW May 22nd 2019, 10:05am |
 |
@lukerehmann Genocea Biosciences $GNCA performed a 1 for 8 reverse split. Fractional shares resulting from the split will be rou… https://t.co/J9BURudIeZ May 22nd 2019, 10:05am |
|
@Tickeron $GNCA Genocea Biosciences (GNCA, $4.75) was the market's top quarterly gainer, rising +19% https://t.co/XDtXkrtUbF May 22nd 2019, 9:05am |
 |
@BeefEnt RT @Stock_News_Now: $GNCA: New SEC Filing for GNCA: Form EFFECT (No. 9999999995-19-001101): https://t.co/fTceUo84x1 May 22nd 2019, 8:05am |
|
@BeefEnt RT @InsiderBiotech: $GNCA briefly before ASCO https://t.co/KSYuLow3zJ May 22nd 2019, 8:05am |
|
@BeefEnt RT @YVR_Trader: $GNCA 1 for 8 R/S effective tomorrow https://t.co/AA7r1O4Rgk May 22nd 2019, 8:05am |
|
@BeefEnt RT @SwingTradeBot: 200 DMA Support today: $GNCA $C ... https://t.co/LjP7KUcNnp May 22nd 2019, 8:05am |
|
@bulletin_en Rigel Pharmaceuticals Inc. $GNCA Comparing side by side https://t.co/HPvkrMi8eQ May 21st 2019, 6:05pm |
 |
@YVR_Trader Who gets bought first $MRKR or $GNCA? May 21st 2019, 4:05pm |
 |
@Matthew96240465 $GNCA is coming out with phase 1/2 data for GEN-009 vaccine for various cancers on June 1, 2019 at ASCO. It’s dippe… https://t.co/od0kWACoUZ May 21st 2019, 10:05am |
|
@YVR_Trader $GNCA 1 for 8 R/S effective tomorrow https://t.co/AA7r1O4Rgk May 21st 2019, 9:05am |
 |
@SwingTradeBot 200 DMA Support today: $GNCA $C ... https://t.co/LjP7KUcNnp May 21st 2019, 9:05am |
 |
@mvonwhy $GNCA reverse split 8:1 effective May 22. https://t.co/3fw71s4dv6 May 21st 2019, 8:05am |
|
@SwingTradeBot 200 DMA Support today: $GNCA ... https://t.co/LjP7KUcNnp May 20th 2019, 2:05pm |
 |
@FlyOnTheWallHQ RT @StockWatchHQ: MedGen $MDIN New Joint Venture With Genocea Biosciences $GNCA, Details To Come, Announcement Pending https://t.co/pycSFqi… May 20th 2019, 10:05am |
 |
@Biotrade_alert Trade Alert: Sold $GNCA at $0.67 with 7% Loss May 20th 2019, 9:05am |
 |
@InsiderBiotech $GNCA briefly before ASCO https://t.co/KSYuLow3zJ May 20th 2019, 8:05am |
 |
@BioBreakout Stocks I am watching for a potential trade... please add to the list with catalyst date in comments $ACHV $GNCA… https://t.co/JrxeJJHBqk May 19th 2019, 9:05pm |
 |
@StockWatchHQ MedGen $MDIN New Joint Venture With Genocea Biosciences $GNCA, Details To Come, Announcement Pending… https://t.co/Gc9QwSWl5e May 19th 2019, 4:05pm |
|
@bulletin_en Reviewing bluebird bio Inc. $GNCA's results https://t.co/ksVb2oJfc3 May 19th 2019, 3:05pm |
 |
@Opal_Chip $GNCA Sold all – at breakeven. The ASCO abstract …meh. Could be something great in clinical responses, but if so,… https://t.co/Vp6utLQKUC May 17th 2019, 3:05pm |
|
@OneMdcn $GNCA Genocea Biosciences (GNCA) Receives a Buy from H.C. Wainwright J. Pantginis PT $5.75 https://t.co/4yoOf3hsMX May 17th 2019, 1:05pm |
 |
@WheyPartyPeople RT @syinvesting: $GNCA on watch list: #ASCO19 abstract showed 93% immune response in 3 pts treated with GEN-009 (Ph 1/2). Potential best-i… May 16th 2019, 6:05pm |
 |
@Madeforprofit1 $GNCA $1.89 cash in hand- I will hold my 50K ????? May 16th 2019, 3:05pm |
 |
@DmdMt24 @AceAnalyst what do you think about $gnca vs. $ntgn May 16th 2019, 3:05pm |
 |
@ramypandey Realtime trade: bought some $gnca at .74 May 16th 2019, 2:05pm |
|
@Lin_ling_88 RT @GenoceaBio: $GNCA and $IOVA enter research collaboration to explore development of next-generation, neoantigen-targeted TIL products. #… May 16th 2019, 2:05pm |
 |
@ledgetop @thejadedtrader Too bad. Hoping this is the beginning of the price improvement for $GNCA in months to come. May 16th 2019, 2:05pm |
 |
@AnthonyRuse @Benzinga That's what I'm talking about!! Get 'em $GNCA lol May 16th 2019, 1:05pm |
 |
@syinvesting $GNCA on watch list: #ASCO19 abstract showed 93% immune response in 3 pts treated with GEN-009 (Ph 1/2). Potential… https://t.co/VwZNg4MbkK May 16th 2019, 1:05pm |
 |
@thejadedtrader Closed out the remainder of my $GNCA. Very high burn rate and have a very long way to go with 011 asset. 93% immu… https://t.co/nxDTfHh8jJ May 16th 2019, 1:05pm |
|
@YVR_Trader Watch $GNCA ??? https://t.co/r1avppMiUF May 16th 2019, 1:05pm |
|
@YVR_Trader @ledgetop There you go..... $GNCA https://t.co/riOOzsJIn6 May 16th 2019, 1:05pm |
 |
@GenoceaBio $GNCA and $IOVA enter research collaboration to explore development of next-generation, neoantigen-targeted TIL pro… https://t.co/2anrVUCyN5 May 16th 2019, 1:05pm |
|
@YVR_Trader RT @TraderTexMex: $GNCA Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infi… May 16th 2019, 1:05pm |
|
@Ultra_Calls $GNCA Genocea Announces Research Collaboration With Iovance to Explore Development of Neoantigen-Targeted TIL (Tumo… https://t.co/xLb4FSzCsD May 16th 2019, 1:05pm |
 |
@TraderTexMex $GNCA Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumo… https://t.co/YogKiCi9rL May 16th 2019, 1:05pm |
 |
@DZalkowitz $IOVA is partnering with $GNCA to evaluate its ATLAS platform to see if it improves the efficacy of TIL therapy May 16th 2019, 10:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.